Summary
1-Acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione (APTD) has hypolipidaemic, anti-inflammatory, analgesic, antineoplastic, and aldose reductase inhibitory activities in animals. Disposition studies using pooled plasma and urine samples showed that [1-14C-acetyl]-1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione (14C-APTD) had a maximum half-life of 20 hours. Urinary excretion accounted for less than 3% of the radioactivity elimination, while faecal excretion may account for up to 45% of the total elimination. In a 96-hour tissue distribution study, there was no sequestering of 14C-APTD in any of the organs. 14C-APTD demonstrated significant aqueous partitioning, and almost no binding to bovine serum albumin. In L1210 tumour cells, 14C-APTD was bound to DNA and RNA, and there was no binding to intracellular protein. 14C-APTD underwent significant metabolism in mice. One metabolite excreted in urine was identified; two other possible metabolites were proposed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chae CB, Williams A, Krasny H, Irvin JL, Piantadosi C. Inhibition of thymidine phosphorylation and DNA and histone synthesis in Ehrlich Ascites carcinoma. Cancer Research 30: 2652–2660, 1970
Gibaldi M, Perrier D. Pharmacokinetics, 2nd edition, pp. 25–26, Marcel Dekker, New York, 1975
Hall IH, Izydore RA, Simlot R. Structure activity relationships of 4-N-substituted 1-acyl and 1,2-diacyl triazolidine-3,5-diones as antiinflammatory agents. Archiv der Pharmazie, in press, 1994
Hall IH, Izydore RA, Simlot R, Wong OT. Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxy-benzoyl)-4,4-diethyl-3,5-isoxazolidinedione. Experientia 48: 383–386, 1992a
Hall IH, Wong OT, Simlot R, Miller MC III, Izydore RA. Antineo-plastic activities and cytotoxicity of 1-acyl and 1,2-diacyl-1,2,4-triazolidine-3,5-diones in murine and human tissue culture cells. Anticancer Research 12: 1355–1361, 1992b
Sartorelli AC. Effect of chelating agents upon the synthesis of nucleic acids and proteins: inhibition of DNA synthesis by 1-formylisoquinoline thiosemicarbazone. Biochemical and Biophysical Research Communications 27: 26–32, 1967
Simlot R, Izydore RA, Wong OT, Hall IH. Synthesis and hypolipidemic activity of 4-substituted 1-acyl-1,2,4-triazolidine-3,5-diones in rodents. Journal of Pharmaceutical Sciences 82: 408–415, 1993
Wilson RG, Bodner RH, MacWhorter GE. Inhibition of macromolecular synthesis in L-1210 mouse leukemia ascites cells by hycanthone. Biochimica et Biophysica Acta 378: 260–268, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shrewsbury, R.P., Wyrick, S.D., Elkins, A.L. et al. Disposition of the Pharmacologically Active Compound [1-14C-Acetyl]-1-Acetyl-4-Phenyl-1,2,4-Triazolidine-3,5-Dione in CF1 Mice. Drug Invest 7, 275–281 (1994). https://doi.org/10.1007/BF03257419
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257419